Our Vision

Statement of strategic intent

At Medefer, we want to be the world’s most patient-focused virtual health service.

We are on a mission to help patients get better faster.

We are partnering with the NHS to build the best outpatient process, helping assess patients more quickly.

To do this work with our partners, we provide technology-enabled clinical and operational expertise, making it better for patients, healthcare professionals and the NHS.

We live by our values

Patient-first
We are determined to deliver an unrivalled healthcare experience for every patient.

Collaborative
We hold a deep-held commitment to creating enabling shared solutions and partnerships for the benefit of all.

Inventive
We challenge conventional thinking and continuously improve our solutions.


Our People

Executive and Senior Management

Dr Bahman Nedjat-Shokouhi

Founder & CEO

Bahman is the founder and Chief Executive Officer of Medefer.

With a deep commitment to patient care and the NHS, Bahman’s vision is to completely transform the way that healthcare is delivered by providing patients with the best – timely, efficient and effective – healthcare experience possible.

The considerable potential for Medefer to develop transformative solutions beyond the current scope of activity is a key driver for Bahman in developing and extending his vision to a broader range of transformative healthcare solutions – with a focus on patient safety and increasing organisational efficiency.

With a Medical Degree from University College London, an intercalated BSc in Neuroscience and a PhD in Molecular Biology and Immunology, Bahman continues to practice as Consultant Gastroenterologist at Whittington Hospital NHS Trust – maintaining his commitment to, and connections within, the NHS. Bahman has also developed educational programmes for international audiences and published papers in leading journals on his work in the NHS and with Medefer.

Dr Simon Carter

Chief Medical Officer

Simon brought a wealth of research and innovation expertise when he joined in 2020.

Dr Simon Carter trained as Urologist at the Institute of Urology and Baylor University, Houston. He was appointed consultant at Charing Cross Hospital, subsequently Imperial Hospitals NHS Trust, in 1993.

He spent the first part of his career designing and investigating novel treatments for benign prostatic disease. He held the post of Chief of Urology and Transplantation. He was seconded part-time to work with Doctor Foster, developing consultant-level clinical outcome metrics. He left the NHS in 2012 to become Medical Director of the London Clinic for 5 years.

He had a substantial private and medicolegal practice until 2019 when he became Medical Director of Medpass International, a consulting firm advising medical device companies from all over the world on product development, clinical investigation, European, US and international regulations and route to market.

Dr Ed Bosonnet

Medical Director for Primary Care

Ed joined Medefer in 2016 bringing his passion for innovation to the team.

Ed qualified as a GP in 2002. With experience in leadership roles in the NHS and as a Member of a Clinical Commissioning Group (CCG) governing body, Ed developed an interest in the potential for innovation in IT to drive both strategy and healthcare delivery. He represented the CCG as its Clinical Quality Lead for the Royal Free Hospital NHS Foundation Trust and developed an interest in IT service development and strategy, becoming the CCG’s Clinical IT Lead.

At Medefer, Ed continues to develop innovative virtual healthcare strategies. He engages with CCGs and primary care  to identify opportunities to support and  extend the reach of Medefer’s unique virtual solutions within the NHS.

Dr Matthew Knight MBE

Deputy Chief Medical Officer

Matthew is Medefer’s Clinical Lead for Respiratory and was made Deputy Medical Director in September 2020.

Matthew was Associate Postgraduate Dean for Medicine at the postgraduate school of Medicine based at Health Education East of England in Cambridge (2017-20) and was the head of department of respiratory medicine at West Hertfordshire Hospitals NHS Trust.

He was the Royal College Tutor for Medicine at West Hertfordshire Hospitals Trust from 2016 to 2020. During the Coronavirus outbreak of 2020 he established and led the COVID Virtual hospital in Hertfordshire.

Matthew has a clinical interest in chronic cough, unexplained breathlessness, cardio-pulmonary exercise testing and upper airway allergy. He has been actively involved in research into emergency pleural disease management and out of hospital care for acute respiratory conditions.

Matthew was awarded an MBE in the Queen’s Birthday Honours List of 2020 for his services to healthcare, in particular for his work with COVID-19.

Katrina Percy

Managing Director

Katrina joined the UK’s National Health Service as a graduate management trainee over 25 years ago. She has worked across all sectors of the health service including internationally. More recently her focus has been on the development and successful implementation of tech and digital health solutions working with a number of leading-edge health technology and digital health businesses, including working as a member of the National Association of Primary Care Faculty. Katrina was an NHS CEO for nearly 10 years, winning the coveted NHS CEO of the year and being named amongst the 50 most inspirational women in healthcare.

She is known for her capability to lead organisations, both big and small through transformational and innovative change. She is particularly passionate about drawing together new care models and digital transformation and supporting its delivery in health systems.

Katrina has joined Medefer to further see this vision put into practice by transforming the outpatient pathway using their unique platform and team capabilities to deliver benefits to patients and the NHS alike.

Megan Grant

Chief Operating Officer

Megan has over 15 years of operational leadership experience of delivering Workforce Management and Recruitment services to the NHS.

Megan is skilled at working with multi-disciplinary teams, designing and delivering high volume, scalable, customer-centric services that are desirable, feasible and viable, using innovative and pragmatic solutions.

“After spending so many years helping to try and solve workforce issues in the NHS, it is incredibly exciting to be working at Medefer, designing and implementing services that transform the model of patient care and not only help to improve health outcomes and patient experience but also alleviate and resolve a number of workforce challenges.” 

Martin Smith

Chief Financial Officer

Martin qualified as a Chartered Accountant before spending more than a decade working in Investment Banking, advising small and mid-cap companies on growth strategies, debt and equity fundraising and mergers and acquisitions. His clients included a number in the Healthcare Sector serving the NHS.

He then moved to Monitor, the independent financial regulator for the NHS where he led the approach to mergers and acquisitions in the NHS. As a Senior Director, he also led multi-disciplinary teams in financial turnaround and other complex situations.

Richard Alexander

Financial Advisor

Rex Cooper

Chief Technology Officer

Rex is Chief Technology Officer at Medefer.

Rex is a specialist in building world class engineering teams that provide a competitive advantage to the company. He has worked across many industries and with companies in different stages, from startups and scale-ups to large corporates.

His previous experience includes CTO roles at LiveHealthily (an online symptom checker and self-care platform) and BMJ as well as Senior leadership roles at The Guardian and RatedPeople.com

“Medefer is improving people’s lives and helping us to make better use of our unique NHS. There are not many jobs where you can say that what you do directly contributes to making the world a better place. I am thrilled to be able say that about working for Medefer”

Jo Sellar

Chief People Officer

Jo has a BSC in Psychology and Physiology from Cardiff University and has spent the past 10 years gaining experience across People functions in both large-scale organisations such as Amazon as well as most recently helping to scale the sports streaming start up DAZN, from scratch.

Having worked within a wide variety of HR specialities and with teams around the globe, Jo is passionate about building an inclusive and engaging culture for employees where people can really thrive and be supported to succeed in their careers!

As we enter an ever-changing healthcare landscape, Jo is excited to be part of growing the business and taking virtual patient support to the next level!

Shelley Garlington

Business Development Director

Shelley has more than 25 years of hands-on health and care experience, going all the way back to her time as a nurse. She helps match ideas, products and services to what the sector needs by drawing on commercial skills developed in the private and public sector. By building the right kind of partnerships and empathy to understand what everyone needs she focuses on better outcomes for patients and better value for the NHS.

‘As a former nurse, patient care and quality outcomes are at the heart of all I do, as such I am thrilled to be part of the national solution to building capacity in elective care as we recover from the effects of the global pandemic. Medefer’s offer builds on all the experiences we have gained in the last year and enables our people to get the care they need faster.’

Board

Stephen Hay

Non-Executive Chairman

Stephen Hay has been Chairman of Medefer since October 2020.

Stephen was Deputy Chief Executive and Executive Director of Regulation at NHS Improvement with responsibility for all regulatory issues across the provider side of the NHS from 2013 – 2019. Prior to that, he was Chief Operating Officer and then Managing Director at Monitor, the regulator of Foundation Trust hospitals, which he helped establish in 2004. In his health sector career he has been responsible for strategic planning, finance, board appointments, sector performance, regulatory interventions and the design/operation of the UK health sector’s failure regime.

Previously Stephen worked for KPMG in a variety of roles within Corporate Finance, Transaction Services and Assurance services where he advised corporate and private equity clients on mergers and acquisitions, IPOs, due diligence and risk management.

Stephen’s other roles have included being a Non-Executive Director on the Board of the Department for Communities and Local Government where he served as Chair of the Audit and Risk Committee for 6 years.

He is currently a Trustee of the World Wildlife Fund in the UK where he also chairs the Audit and Risk Committee. Additionally, Stephen is a member of the World Wildlife Fund International Audit and Risk Committee based in Switzerland.

Pam Garside

Non-Executive Director

Pam Garside is a management consultant working in health care systems and digital health in the UK and internationally and an angel investor in early stage health tech companies. She is a Fellow of the Judge Business School of the University of Cambridge and a member of the Investment Committee of Cambridge Enterprise, the technology transfer company of the University. Pam founded and co-chairs The Cambridge Health Network, a membership group of senior players in UK health, both private and public sector. She is a board member of Cambridge Angels, Crown Place VCT, several start-ups and Whizz-Kidz and Punchdrunk charities. Pam is advises a number of health technology accelerators in the UK.

Pam began her professional life in management in the NHS and subsequently spent many years studying and working internationally based in the USA. She holds a BSc from the University of Durham and a Masters Degree in Hospital and Health Care Administration from the University of Minnesota. She is an Adjunct Professor at Imperial College Business School.

‘I have been involved with Medefer for four years , it has been great to see the company grow to where it is now, offering an important service to the NHS and working with partners across the country at this time when face to face services are more challenging to deliver’

Jonathan Quinn

Non-Executive Director

Jonathan became of a director and shareholder of Medefer in August 2020. He was brought up in a medical family (his father was a surgeon and his mother a GP), and he holds a strong belief in Medefer’s potential to build a great ethical business transforming outpatient care for the better.

He currently holds investments in fifteen technology businesses, is a trustee of a UK-based Charitable Trust, is a Senior Advisor to Ant Group, and is also a director of World First UK Limited. Jonathan co-founded World First in 2004, with the goal of making it faster, easier, safer and cheaper to make international payments. The business grew to 700 people and $15billion of turnover, was in the top 100 fastest growing companies five times, was twice awarded the Queen’s Award for Enterprise, and Jonathan was a finalist in the EY Entrepreneur of the Year awards. World First was acquired by the Ant Group in 2019.

Prior to World First, Jonathan worked in the financial markets division of RBS and before that at Citibank. He grew up in Scotland and has a Law and Accountancy degree from Edinburgh University. 

Jonathan lives in South London with his wife and two daughters, but spends as much time as possible on the Isle of Mull. His interests include art, architecture, design, music, cars, and business.

Bruce Bower

Non-Executive Director

Bruce is a private investor based in London, with interests in technology, health and media.  He is a non-executive director of Medefer, Support Room, and Life & Soul Pictures. He helps early-stage companies with strategy, finance and fundraising.  Previously, he was a Portfolio Manager and a Partner at Verno Capital, a Russia-focused investment fund with a peak of $5 billion under management or advisory.  He began his career at Citigroup as a proprietary trader in the FX and Rates division.

Bruce is the author of “Peak Performance of Trading and Investing”.  He holds a BA from the University of Chicago and a MSc from the London School of Economics.

He has been involved with Medefer since the beginning. He loves that the company is addressing a huge unmet need for society with an innovative technological solution.

Saav Shah

Non-Executive Director

Saav is a partner at Nickleby Capital, an investment house backed by family offices and entrepreneurs.

Prior to joining Nickleby Capital, Saav ran the co-investment division of Chrystal Capital.

He advised a small group of family offices and UHNWIs, investing between £2-£15m into European private equity opportunities including Neo4J, MotoCaddy, Docplanner, Coople, Le Tote and Candid.

Saav began his career in the investment banking divisions of Rothschild, Goldman Sachs and Commerzbank.

Advisory Board

Rt Hon Patricia Hewitt

Rt Hon Patricia Hewitt has been the independent chair of the Norfolk and Waveney Integrated Care System since 2017.

Patricia had a long and distinguished career in politics and government, serving in the Blair Cabinet as Secretary of State for Health (2005 to 2007), Trade and Industry Secretary and Cabinetr Minister for Women (2001-2005). She has a long-standing interest in digital transformation, working closely with healthcare leaders in Australia and India as well as the UK. After retiring from Parliament in 2010, Patricia served as Chair of the UK India Business Council, promoting closer relationships between the two countries in healthcare, life sciences and other sectors. She is an adviser to the UK Board of Trade, a non-executive director of Getlink and a senior adviser to FTI Consulting.

Professor Sir Mike Richards

Professor Sir Mike Richards was a hospital physician for more than 20 years. After a variety of training posts, he was a consultant medical oncologist between 1986 and 1995, and Professor of Palliative Medicine at Guy’s and St. Thomas’ Hospitals between 1995 and 1999.

In 1999 Sir Mike was appointed as the first National Cancer Director at the Department of Health. He led the development and implementation of the NHS Cancer Plan in 2000, the Cancer Reform Strategy in 2007 and Improving Outcomes: A strategy for cancer in 2011.

He became CQC’s first Chief Inspector of Hospitals in July 2013 and led the development and implementation of a new approach to hospital inspection. Sir Mike retired from this role at the end of July 2017.

Sir Mike was awarded a CBE in 2001 and appointed a Knight Bachelor in 2010

He has recently led two major reviews for NHS England: A review of adult screening services (published 2019) and a review of diagnostic services (published October 2020). This recommends a major expansion of diagnostic capacity and a new model of service delivery.

“Medefer has the potential to transform pathways to diagnosis for a very large number of patients, thereby improving patient experience and clinical outcomes.  I am delighted to be a member of the Clinical advisory Group.”

Sir Cyril Chantler

Cyril Chantler was Professor of Paediatric Nephrology and Consultant Paediatrician at Guys Hospital until 2000. He was Principal of Guy’s and St Thomas’s Hospitals Medical and Dental Schools(1992 – 1998) and Chairman of the management board of Guy’s Hospital (1985-1988). He was Chairman of Great Ormond Street Hospital (2001- 2008) and the Kings Fund (2004-2010), 

He received a knighthood for services to medicine in 1996. In January 2017 he was made a Knight Grand Cross of the Order of the British Empire (GBE) for Services to Leadership in Healthcare.

In addition, he served as a member of the Member of the NHS Policy Board (1989-1996), President of the British Association of Medical Managers (1991-1997), and as Chairman of the Council of Heads of UK Medical Schools and Faculties (1998 –1999). He was also a Member of the General Medical Council (1994–2003), where he was Chairman of the Standards Committee. He served for some years as an adviser to the Hospital Authority of Hong Kong and co-chaired the SARS expert advisory enquiry in 2003.His other previous appointments include non-executive Director of the Guy’s/Lewisham Trust (1991-92) and of the Guy’s and St Thomas’ NHS Trust (1993-97).  In addition he was Pro-Vice Chancellor, University of London (1997-2000). He was co-editor of Paediatric Nephrology from 1985 to 1996.  He served as a Member of the Council of St. George’s Medical School (2000–2003) and of the Board of Governors of London South Bank University (2002-2005).  He was Medical Director of Well Child (2001-2005), a trustee of the Dunhill Medical Trust (2001-2009) and of the British Kidney Patients Association (2007-2010). He served as Chairman of the Strategic Advisory Group for the development of Dulwich Community Hospital (2000-2005). He was Chairman of the Shared Medical Record Committee of the Care Record Development Board of Connecting for Health, and has also been involved in a number of inquiries into the provision of acute paediatric services in various parts of England. 

He was elected as an Honorary Member of the American Paediatric Society in 1991 and as a Foreign Associate of the National Academy of Medicine USA in 1999.  Cyril Chantler is a Fellow of Kings College, London, an Honorary Fellow of the Institute of Child Health London, and received an Honorary Fellowship of the Royal College of Surgeons of England in 2018 and the Royal College of Obstetricians and Gynaecologists in 2019. He has honorary degrees from London South Bank University, the University of Lille, France, the University of London, the University of Kent and University College London. He was awarded the James Spence Medal of the Royal College of Paediatrics and Child Health in 2005 and the Ira Greifer Award of the International Pediatric Nephrology Association in 2007. In 2015 he was awarded the Otto Wolff Medal by the Royal Society of Medicine. 

Sir David Dalton

Sir David has been an NHS Chief Executive for 25 years, serving at Salford Royal for 17+ years – rated ‘outstanding’ by the Care Quality Commission in each consecutive year and designated as a Global Digital Exemplar, following the creation of one of first integrated digital care records in the NHS.

He led the Northern Care Alliance, creating 5 new integrated Care Organisations in Greater Manchester.  He has a particular interest in supporting improvement and empowering staff – with a focus on patient safety.  He produced the first Quality Improvement Strategy for an NHS Trust with an explicit aim of saving lives and reducing harm.

He was knighted in 2014 for his services to Healthcare. He was a member of the ‘Berwick Review’, which advised the government on patient safety improvements and co-chaired a national review to support openness in reporting harmful events. In 2014 he led the Dalton Review which recommended actions to assure high quality healthcare was delivered through sustainable NHS organisations.

“Medefer provides the missing piece for the NHS in its search for a partner to deliver better healthcare, quicker and more reliably than it can do on its own.”

Our People

Executive and Senior Management

Dr Bahman Nedjat-Shokouhi

Founder & CEO

Bahman is the founder and Chief Executive Officer of Medefer.

With a deep commitment to patient care and the NHS, Bahman’s vision is to completely transform the way that healthcare is delivered by providing patients with the best – timely, efficient and effective – healthcare experience possible.

The considerable potential for Medefer to develop transformative solutions beyond the current scope of activity is a key driver for Bahman in developing and extending his vision to a broader range of transformative healthcare solutions – with a focus on patient safety and increasing organisational efficiency.

With a Medical Degree from University College London, an intercalated BSc in Neuroscience and a PhD in Molecular Biology and Immunology, Bahman continues to practice as Consultant Gastroenterologist at Whittington Hospital NHS Trust – maintaining his commitment to, and connections within, the NHS. Bahman has also developed educational programmes for international audiences and published papers in leading journals on his work in the NHS and with Medefer.

Dr Simon Carter

Chief Medical Officer

Simon brought a wealth of research and innovation expertise when he joined in 2020.

Dr Simon Carter trained as Urologist at the Institute of Urology and Baylor University, Houston. He was appointed consultant at Charing Cross Hospital, subsequently Imperial Hospitals NHS Trust, in 1993.

He spent the first part of his career designing and investigating novel treatments for benign prostatic disease. He held the post of Chief of Urology and Transplantation. He was seconded part-time to work with Doctor Foster, developing consultant-level clinical outcome metrics. He left the NHS in 2012 to become Medical Director of the London Clinic for 5 years.

He had a substantial private and medicolegal practice until 2019 when he became Medical Director of Medpass International, a consulting firm advising medical device companies from all over the world on product development, clinical investigation, European, US and international regulations and route to market.

Dr Ed Bosonnet

Medical Director for Primary Care

Ed joined Medefer in 2016 bringing his passion for innovation to the team.

Ed qualified as a GP in 2002. With experience in leadership roles in the NHS and as a Member of a Clinical Commissioning Group (CCG) governing body, Ed developed an interest in the potential for innovation in IT to drive both strategy and healthcare delivery. He represented the CCG as its Clinical Quality Lead for the Royal Free Hospital NHS Foundation Trust and developed an interest in IT service development and strategy, becoming the CCG’s Clinical IT Lead.

At Medefer, Ed continues to develop innovative virtual healthcare strategies. He engages with CCGs and primary care  to identify opportunities to support and  extend the reach of Medefer’s unique virtual solutions within the NHS.

Dr Matthew Knight MBE

Deputy Chief Medical Officer

Matthew is Medefer’s Clinical Lead for Respiratory and was made Deputy Medical Director in September 2020.

Matthew was Associate Postgraduate Dean for Medicine at the postgraduate school of Medicine based at Health Education East of England in Cambridge (2017-20) and was the head of department of respiratory medicine at West Hertfordshire Hospitals NHS Trust.

He was the Royal College Tutor for Medicine at West Hertfordshire Hospitals Trust from 2016 to 2020. During the Coronavirus outbreak of 2020 he established and led the COVID Virtual hospital in Hertfordshire.

Matthew has a clinical interest in chronic cough, unexplained breathlessness, cardio-pulmonary exercise testing and upper airway allergy. He has been actively involved in research into emergency pleural disease management and out of hospital care for acute respiratory conditions.

Matthew was awarded an MBE in the Queen’s Birthday Honours List of 2020 for his services to healthcare, in particular for his work with COVID-19.

Katrina Percy

Managing Director

Katrina joined the UK’s National Health Service as a graduate management trainee over 25 years ago. She has worked across all sectors of the health service including internationally. More recently her focus has been on the development and successful implementation of tech and digital health solutions working with a number of leading-edge health technology and digital health businesses, including working as a member of the National Association of Primary Care Faculty. Katrina was an NHS CEO for nearly 10 years, winning the coveted NHS CEO of the year and being named amongst the 50 most inspirational women in healthcare.

She is known for her capability to lead organisations, both big and small through transformational and innovative change. She is particularly passionate about drawing together new care models and digital transformation and supporting its delivery in health systems.

Katrina has joined Medefer to further see this vision put into practice by transforming the outpatient pathway using their unique platform and team capabilities to deliver benefits to patients and the NHS alike.

Megan Grant

Chief Operating Officer

Megan has over 15 years of operational leadership experience of delivering Workforce Management and Recruitment services to the NHS.

Megan is skilled at working with multi-disciplinary teams, designing and delivering high volume, scalable, customer-centric services that are desirable, feasible and viable, using innovative and pragmatic solutions.

“After spending so many years helping to try and solve workforce issues in the NHS, it is incredibly exciting to be working at Medefer, designing and implementing services that transform the model of patient care and not only help to improve health outcomes and patient experience but also alleviate and resolve a number of workforce challenges.” 

Martin Smith

Chief Financial Officer

Martin qualified as a Chartered Accountant before spending more than a decade working in Investment Banking, advising small and mid-cap companies on growth strategies, debt and equity fundraising and mergers and acquisitions. His clients included a number in the Healthcare Sector serving the NHS.

He then moved to Monitor, the independent financial regulator for the NHS where he led the approach to mergers and acquisitions in the NHS. As a Senior Director, he also led multi-disciplinary teams in financial turnaround and other complex situations.

Richard Alexander

Financial Advisor

Rex Cooper

Chief Technology Officer

Rex is Chief Technology Officer at Medefer.

Rex is a specialist in building world class engineering teams that provide a competitive advantage to the company. He has worked across many industries and with companies in different stages, from startups and scale-ups to large corporates.

His previous experience includes CTO roles at LiveHealthily (an online symptom checker and self-care platform) and BMJ as well as Senior leadership roles at The Guardian and RatedPeople.com

“Medefer is improving people’s lives and helping us to make better use of our unique NHS. There are not many jobs where you can say that what you do directly contributes to making the world a better place. I am thrilled to be able say that about working for Medefer”

Jo Sellar

Chief People Officer

Jo has a BSC in Psychology and Physiology from Cardiff University and has spent the past 10 years gaining experience across People functions in both large-scale organisations such as Amazon as well as most recently helping to scale the sports streaming start up DAZN, from scratch.

Having worked within a wide variety of HR specialities and with teams around the globe, Jo is passionate about building an inclusive and engaging culture for employees where people can really thrive and be supported to succeed in their careers!

As we enter an ever-changing healthcare landscape, Jo is excited to be part of growing the business and taking virtual patient support to the next level!

Shelley Garlington

Business Development Director

Shelley has more than 25 years of hands-on health and care experience, going all the way back to her time as a nurse. She helps match ideas, products and services to what the sector needs by drawing on commercial skills developed in the private and public sector. By building the right kind of partnerships and empathy to understand what everyone needs she focuses on better outcomes for patients and better value for the NHS.

‘As a former nurse, patient care and quality outcomes are at the heart of all I do, as such I am thrilled to be part of the national solution to building capacity in elective care as we recover from the effects of the global pandemic. Medefer’s offer builds on all the experiences we have gained in the last year and enables our people to get the care they need faster.’

Board

Stephen Hay

Non-Executive Chairman

Stephen Hay has been Chairman of Medefer since October 2020.

Stephen was Deputy Chief Executive and Executive Director of Regulation at NHS Improvement with responsibility for all regulatory issues across the provider side of the NHS from 2013 – 2019. Prior to that, he was Chief Operating Officer and then Managing Director at Monitor, the regulator of Foundation Trust hospitals, which he helped establish in 2004. In his health sector career he has been responsible for strategic planning, finance, board appointments, sector performance, regulatory interventions and the design/operation of the UK health sector’s failure regime.

Previously Stephen worked for KPMG in a variety of roles within Corporate Finance, Transaction Services and Assurance services where he advised corporate and private equity clients on mergers and acquisitions, IPOs, due diligence and risk management.

Stephen’s other roles have included being a Non-Executive Director on the Board of the Department for Communities and Local Government where he served as Chair of the Audit and Risk Committee for 6 years.

He is currently a Trustee of the World Wildlife Fund in the UK where he also chairs the Audit and Risk Committee. Additionally, Stephen is a member of the World Wildlife Fund International Audit and Risk Committee based in Switzerland.

Pam Garside

Non-Executive Director

Pam Garside is a management consultant working in health care systems and digital health in the UK and internationally and an angel investor in early stage health tech companies. She is a Fellow of the Judge Business School of the University of Cambridge and a member of the Investment Committee of Cambridge Enterprise, the technology transfer company of the University. Pam founded and co-chairs The Cambridge Health Network, a membership group of senior players in UK health, both private and public sector. She is a board member of Cambridge Angels, Crown Place VCT, several start-ups and Whizz-Kidz and Punchdrunk charities. Pam is advises a number of health technology accelerators in the UK.

Pam began her professional life in management in the NHS and subsequently spent many years studying and working internationally based in the USA. She holds a BSc from the University of Durham and a Masters Degree in Hospital and Health Care Administration from the University of Minnesota. She is an Adjunct Professor at Imperial College Business School.

‘I have been involved with Medefer for four years , it has been great to see the company grow to where it is now, offering an important service to the NHS and working with partners across the country at this time when face to face services are more challenging to deliver’

Jonathan Quinn

Non-Executive Director

Jonathan became of a director and shareholder of Medefer in August 2020. He was brought up in a medical family (his father was a surgeon and his mother a GP), and he holds a strong belief in Medefer’s potential to build a great ethical business transforming outpatient care for the better.

He currently holds investments in fifteen technology businesses, is a trustee of a UK-based Charitable Trust, is a Senior Advisor to Ant Group, and is also a director of World First UK Limited. Jonathan co-founded World First in 2004, with the goal of making it faster, easier, safer and cheaper to make international payments. The business grew to 700 people and $15billion of turnover, was in the top 100 fastest growing companies five times, was twice awarded the Queen’s Award for Enterprise, and Jonathan was a finalist in the EY Entrepreneur of the Year awards. World First was acquired by the Ant Group in 2019.

Prior to World First, Jonathan worked in the financial markets division of RBS and before that at Citibank. He grew up in Scotland and has a Law and Accountancy degree from Edinburgh University. 

Jonathan lives in South London with his wife and two daughters, but spends as much time as possible on the Isle of Mull. His interests include art, architecture, design, music, cars, and business.

Bruce Bower

Non-Executive Director

Bruce is a private investor based in London, with interests in technology, health and media.  He is a non-executive director of Medefer, Support Room, and Life & Soul Pictures. He helps early-stage companies with strategy, finance and fundraising.  Previously, he was a Portfolio Manager and a Partner at Verno Capital, a Russia-focused investment fund with a peak of $5 billion under management or advisory.  He began his career at Citigroup as a proprietary trader in the FX and Rates division.

Bruce is the author of “Peak Performance of Trading and Investing”.  He holds a BA from the University of Chicago and a MSc from the London School of Economics.

He has been involved with Medefer since the beginning. He loves that the company is addressing a huge unmet need for society with an innovative technological solution.

Saav Shah

Non-Executive Director

Saav is a partner at Nickleby Capital, an investment house backed by family offices and entrepreneurs.

Prior to joining Nickleby Capital, Saav ran the co-investment division of Chrystal Capital.

He advised a small group of family offices and UHNWIs, investing between £2-£15m into European private equity opportunities including Neo4J, MotoCaddy, Docplanner, Coople, Le Tote and Candid.

Saav began his career in the investment banking divisions of Rothschild, Goldman Sachs and Commerzbank.

Advisory Board

Rt Hon Patricia Hewitt

Rt Hon Patricia Hewitt has been the independent chair of the Norfolk and Waveney Integrated Care System since 2017.

Patricia had a long and distinguished career in politics and government, serving in the Blair Cabinet as Secretary of State for Health (2005 to 2007), Trade and Industry Secretary and Cabinetr Minister for Women (2001-2005). She has a long-standing interest in digital transformation, working closely with healthcare leaders in Australia and India as well as the UK. After retiring from Parliament in 2010, Patricia served as Chair of the UK India Business Council, promoting closer relationships between the two countries in healthcare, life sciences and other sectors. She is an adviser to the UK Board of Trade, a non-executive director of Getlink and a senior adviser to FTI Consulting.

Professor Sir Mike Richards

Professor Sir Mike Richards was a hospital physician for more than 20 years. After a variety of training posts, he was a consultant medical oncologist between 1986 and 1995, and Professor of Palliative Medicine at Guy’s and St. Thomas’ Hospitals between 1995 and 1999.

In 1999 Sir Mike was appointed as the first National Cancer Director at the Department of Health. He led the development and implementation of the NHS Cancer Plan in 2000, the Cancer Reform Strategy in 2007 and Improving Outcomes: A strategy for cancer in 2011.

He became CQC’s first Chief Inspector of Hospitals in July 2013 and led the development and implementation of a new approach to hospital inspection. Sir Mike retired from this role at the end of July 2017.

Sir Mike was awarded a CBE in 2001 and appointed a Knight Bachelor in 2010

He has recently led two major reviews for NHS England: A review of adult screening services (published 2019) and a review of diagnostic services (published October 2020). This recommends a major expansion of diagnostic capacity and a new model of service delivery.

“Medefer has the potential to transform pathways to diagnosis for a very large number of patients, thereby improving patient experience and clinical outcomes.  I am delighted to be a member of the Clinical advisory Group.”

Sir Cyril Chantler

Cyril Chantler was Professor of Paediatric Nephrology and Consultant Paediatrician at Guys Hospital until 2000. He was Principal of Guy’s and St Thomas’s Hospitals Medical and Dental Schools(1992 – 1998) and Chairman of the management board of Guy’s Hospital (1985-1988). He was Chairman of Great Ormond Street Hospital (2001- 2008) and the Kings Fund (2004-2010), 

He received a knighthood for services to medicine in 1996. In January 2017 he was made a Knight Grand Cross of the Order of the British Empire (GBE) for Services to Leadership in Healthcare.

In addition, he served as a member of the Member of the NHS Policy Board (1989-1996), President of the British Association of Medical Managers (1991-1997), and as Chairman of the Council of Heads of UK Medical Schools and Faculties (1998 –1999). He was also a Member of the General Medical Council (1994–2003), where he was Chairman of the Standards Committee. He served for some years as an adviser to the Hospital Authority of Hong Kong and co-chaired the SARS expert advisory enquiry in 2003.His other previous appointments include non-executive Director of the Guy’s/Lewisham Trust (1991-92) and of the Guy’s and St Thomas’ NHS Trust (1993-97).  In addition he was Pro-Vice Chancellor, University of London (1997-2000). He was co-editor of Paediatric Nephrology from 1985 to 1996.  He served as a Member of the Council of St. George’s Medical School (2000–2003) and of the Board of Governors of London South Bank University (2002-2005).  He was Medical Director of Well Child (2001-2005), a trustee of the Dunhill Medical Trust (2001-2009) and of the British Kidney Patients Association (2007-2010). He served as Chairman of the Strategic Advisory Group for the development of Dulwich Community Hospital (2000-2005). He was Chairman of the Shared Medical Record Committee of the Care Record Development Board of Connecting for Health, and has also been involved in a number of inquiries into the provision of acute paediatric services in various parts of England. 

He was elected as an Honorary Member of the American Paediatric Society in 1991 and as a Foreign Associate of the National Academy of Medicine USA in 1999.  Cyril Chantler is a Fellow of Kings College, London, an Honorary Fellow of the Institute of Child Health London, and received an Honorary Fellowship of the Royal College of Surgeons of England in 2018 and the Royal College of Obstetricians and Gynaecologists in 2019. He has honorary degrees from London South Bank University, the University of Lille, France, the University of London, the University of Kent and University College London. He was awarded the James Spence Medal of the Royal College of Paediatrics and Child Health in 2005 and the Ira Greifer Award of the International Pediatric Nephrology Association in 2007. In 2015 he was awarded the Otto Wolff Medal by the Royal Society of Medicine. 

Sir David Dalton

Sir David has been an NHS Chief Executive for 25 years, serving at Salford Royal for 17+ years – rated ‘outstanding’ by the Care Quality Commission in each consecutive year and designated as a Global Digital Exemplar, following the creation of one of first integrated digital care records in the NHS.

He led the Northern Care Alliance, creating 5 new integrated Care Organisations in Greater Manchester.  He has a particular interest in supporting improvement and empowering staff – with a focus on patient safety.  He produced the first Quality Improvement Strategy for an NHS Trust with an explicit aim of saving lives and reducing harm.

He was knighted in 2014 for his services to Healthcare. He was a member of the ‘Berwick Review’, which advised the government on patient safety improvements and co-chaired a national review to support openness in reporting harmful events. In 2014 he led the Dalton Review which recommended actions to assure high quality healthcare was delivered through sustainable NHS organisations.

“Medefer provides the missing piece for the NHS in its search for a partner to deliver better healthcare, quicker and more reliably than it can do on its own.”